• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 受体在人乳腺癌细胞中的缺失促进上皮间质细胞转化和骨骼定植。

Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization.

机构信息

Bone Research Program, ANZAC Research Institute and Concord Medical School, The University of Sydney, Sydney, Australia.

Division of Bone Biology, Garvan Institute of Medical Research, and St. Vincent's Clinical School, University of New South Wales, Sydney, Australia.

出版信息

J Bone Miner Res. 2019 Sep;34(9):1721-1732. doi: 10.1002/jbmr.3744. Epub 2019 Jun 25.

DOI:10.1002/jbmr.3744
PMID:30995345
Abstract

Expression of the vitamin D receptor (VDR) is thought to be associated with neoplastic progression. However, the role of the VDR in breast cancer metastasis to bone and the molecular mechanisms underlying this process are unknown. Employing a rodent model (female Balb/c nu/nu mice) of systemic metastasis, we here demonstrate that knockdown of the VDR strongly increases the metastatic potential of MDA-MB-231 human breast cancer cells to bone, resulting in significantly greater skeletal tumor burden. Ablation of VDR expression promotes cancer cell mobility (migration) and invasiveness, thereby facilitating skeletal colonization. Mechanistically, these changes in tumor cell behavior are attributable to shifts in the expression of proteins involved in cell adhesion, proliferation, and cytoskeletal organization, patterns characteristic for epithelial-to-mesenchymal cell transition (EMT). In keeping with these experimental findings, analyses of human breast cancer specimens corroborated the association between VDR expression, EMT-typical changes in protein expression patterns, and clinical prognosis. Loss of the VDR in human breast cancer cells marks a critical point in oncogenesis by inducing EMT, promoting the dissemination of cancer cells, and facilitating the formation of tumor colonies in bone. © 2019 American Society for Bone and Mineral Research.

摘要

维生素 D 受体 (VDR) 的表达被认为与肿瘤的进展有关。然而,VDR 在乳腺癌骨转移中的作用及其分子机制尚不清楚。我们采用一种系统性转移的啮齿动物模型(雌性 Balb/c nu/nu 小鼠),在此证明 VDR 的敲低强烈增加了 MDA-MB-231 人乳腺癌细胞向骨骼转移的潜力,导致骨骼肿瘤负担显著增加。VDR 表达的缺失促进了癌细胞的迁移和侵袭,从而促进了骨骼定植。从机制上讲,这些肿瘤细胞行为的变化归因于参与细胞黏附、增殖和细胞骨架组织的蛋白表达模式的改变,这些改变是上皮-间充质细胞转化(EMT)的特征。与这些实验结果一致,对人类乳腺癌标本的分析证实了 VDR 表达与 EMT 典型蛋白表达模式变化之间的关联,以及与临床预后的关联。人乳腺癌细胞中 VDR 的缺失通过诱导 EMT 标记了致癌作用的一个关键点,促进了癌细胞的扩散,并促进了肿瘤细胞在骨骼中形成菌落。版权所有© 2019 美国骨骼与矿物质研究协会。

相似文献

1
Loss of the Vitamin D Receptor in Human Breast Cancer Cells Promotes Epithelial to Mesenchymal Cell Transition and Skeletal Colonization.维生素 D 受体在人乳腺癌细胞中的缺失促进上皮间质细胞转化和骨骼定植。
J Bone Miner Res. 2019 Sep;34(9):1721-1732. doi: 10.1002/jbmr.3744. Epub 2019 Jun 25.
2
VDR status arbitrates the prometastatic effects of tumor-associated macrophages.维生素D受体状态可调节肿瘤相关巨噬细胞的促转移作用。
Mol Cancer Res. 2014 Aug;12(8):1181-91. doi: 10.1158/1541-7786.MCR-14-0036. Epub 2014 May 12.
3
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.Linck 促进了乳腺癌的发生,促进了增殖和上皮间质转化。
J Hematol Oncol. 2019 Feb 22;12(1):19. doi: 10.1186/s13045-019-0707-8.
4
WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.WSZG 通过调节 TGF-β1/Smads 信号通路抑制骨髓间充质干细胞诱导的 EMT 和乳腺癌骨转移。
Biomed Pharmacother. 2020 Jan;121:109617. doi: 10.1016/j.biopha.2019.109617. Epub 2019 Nov 22.
5
The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.维生素D受体通过在细胞质中不依赖配体的功能参与人类乳腺癌细胞生长的调控。
Oncotarget. 2017 Apr 18;8(16):26687-26701. doi: 10.18632/oncotarget.15803.
6
miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.miR-1204 靶向 VDR 促进乳腺癌上皮-间充质转化和转移。
Oncogene. 2018 Jun;37(25):3426-3439. doi: 10.1038/s41388-018-0215-2. Epub 2018 Mar 20.
7
Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.维生素 D 缺乏促进 MCF-7 人乳腺癌在骨质硬化性骨转移的啮齿动物模型中的生长。
Bone. 2010 Oct;47(4):795-803. doi: 10.1016/j.bone.2010.07.012. Epub 2010 Jul 16.
8
VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.血管内皮生长因子/神经纤毛蛋白-1轴通过增强上皮-间质转化以及激活核因子-κB和β-连环蛋白来促进乳腺癌进展。
Cancer Lett. 2016 Apr 1;373(1):1-11. doi: 10.1016/j.canlet.2016.01.010. Epub 2016 Jan 19.
9
Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.岩藻聚糖硫酸酯通过增强泛素依赖性 TGFβ 受体降解来诱导乳腺癌上皮间质转化并降低转移。
Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.
10
1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis.1α,25-二羟基维生素D在乳腺癌向骨转移的体外模型中抑制MCF10CA1a和MDA-MB-231细胞的转移能力。
Nutr Cancer. 2016 Oct;68(7):1202-9. doi: 10.1080/01635581.2016.1213868. Epub 2016 Aug 23.

引用本文的文献

1
Relationship of vitamin D receptor expression with hormone receptors and other clinicopathological features in primary breast carcinomas: A retrospective cross-sectional study.原发性乳腺癌中维生素D受体表达与激素受体及其他临床病理特征的关系:一项回顾性横断面研究。
Medicine (Baltimore). 2025 Aug 29;104(35):e44222. doi: 10.1097/MD.0000000000044222.
2
Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy.维生素D受体和APRO家族蛋白在癌症干细胞靶向恶性肿瘤治疗发展中的潜在作用。
Oncol Res. 2025 Apr 18;33(5):1007-1017. doi: 10.32604/or.2025.059657. eCollection 2025.
3
Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms.
维生素 D 在乳腺癌中的多方面作用:基于遗传和途径的系统评价机制。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3349-3361. doi: 10.31557/APJCP.2024.25.10.3349.
4
Targeting nuclear hormone receptors for the prevention of breast cancer.靶向核激素受体预防乳腺癌。
Front Med (Lausanne). 2023 Jul 31;10:1200947. doi: 10.3389/fmed.2023.1200947. eCollection 2023.
5
Research progress of bone metastases: From disease recognition to clinical practice.骨转移的研究进展:从疾病认知到临床实践
Front Oncol. 2023 Jan 25;12:1105745. doi: 10.3389/fonc.2022.1105745. eCollection 2022.
6
Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1.不同原发起源的骨转移瘤常表达维生素D受体(VDR)和CYP24A1。
J Clin Med. 2022 Nov 3;11(21):6537. doi: 10.3390/jcm11216537.
7
Editorial: The bone/bone marrow microenvironment: A hub for immune regulation of the tumor cells fate.社论:骨/骨髓微环境:肿瘤细胞命运免疫调节的中心
Front Immunol. 2022 Aug 31;13:1019489. doi: 10.3389/fimmu.2022.1019489. eCollection 2022.
8
Atropine Is a Suppressor of Epithelial-Mesenchymal Transition (EMT) That Reduces Stemness in Drug-Resistant Breast Cancer Cells.阿托品可抑制上皮间质转化(EMT),降低耐药乳腺癌细胞的干性。
Int J Mol Sci. 2022 Aug 30;23(17):9849. doi: 10.3390/ijms23179849.
9
Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival.维生素 D 水平和维生素 D 受体的表达与乳腺癌风险和生存的关系。
Nutrients. 2022 Aug 16;14(16):3353. doi: 10.3390/nu14163353.
10
Vitamin D, Th17 Lymphocytes, and Breast Cancer.维生素D、辅助性T细胞17与乳腺癌
Cancers (Basel). 2022 Jul 27;14(15):3649. doi: 10.3390/cancers14153649.